Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Dishy

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|June 20, 2018
Coadministration of probenecid and cimetidine with mirogabalin in healthy subjects: A phase 1, randomized, open-label, drug-drug interaction studyMasaya Tachibana, Naotoshi Yamamura, George J Atiee, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 18, 2004
N-Acetylcysteine ameliorates lithium-induced renal failure in ratsShai Efrati, Michael Averbukh, Sylvia Berman, et al.
Thrombosis Research|August 24, 2015
The impact of a three-factor prothrombin complex concentrate on the anticoagulatory effects of the factor Xa inhibitor edoxabanKaren S Brown, Prachi Wickremasingha, Dolly A Parasrampuria, et al.
Clinical Pharmacology in Drug Development|June 6, 2018
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug-Drug Interaction Studies in Healthy SubjectsMendel Jansen, Jeanne Mendell, Alexander Currie, et al.
Journal of Hypertension|January 25, 2003
Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responsesVictor Dishy, Gbenga G Sofowora, Hitoshi Imamura, et al.
Kidney International|November 25, 2003
The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiographyShai Efrati, Victor Dishy, Michael Averbukh, et al.
Thrombosis and Haemostasis|January 9, 2015
Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysisDolly A Parasrampuria, Thomas Marbury, Nobujo Matsushima, et al.
American Journal of Obstetrics and Gynecology|November 20, 2002
beta2-Adrenergic receptor genotype and preterm deliveryRuth Landau, Hong-Guang Xie, Victor Dishy, et al.
American Journal of Therapeutics|May 17, 2014
Effects of Extended-Release Niacin and Extended-Release Niacin/Laropiprant on the Pharmacokinetics of Simvastatin in Healthy SubjectsBrett Lauring, Victor Dishy, Pieter-Jan De Kam, et al.
Journal of Clinical Pharmacology|June 28, 2019
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of an Oral Formulation of DS-1040, an Inhibitor of the Activated Form of Thrombin-Activatable Fibrinolysis Inhibitor, in Healthy SubjectsJin Zhou, Tharin Limsakun, Ophelia Yin, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|June 20, 2018
Coadministration of probenecid and cimetidine with mirogabalin in healthy subjects: A phase 1, randomized, open-label, drug-drug interaction studyMasaya Tachibana, Naotoshi Yamamura, George J Atiee, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 18, 2004
N-Acetylcysteine ameliorates lithium-induced renal failure in ratsShai Efrati, Michael Averbukh, Sylvia Berman, et al.
Thrombosis Research|August 24, 2015
The impact of a three-factor prothrombin complex concentrate on the anticoagulatory effects of the factor Xa inhibitor edoxabanKaren S Brown, Prachi Wickremasingha, Dolly A Parasrampuria, et al.
Clinical Pharmacology in Drug Development|June 6, 2018
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug-Drug Interaction Studies in Healthy SubjectsMendel Jansen, Jeanne Mendell, Alexander Currie, et al.
Journal of Hypertension|January 25, 2003
Nitric oxide production decreases after salt loading but is not related to blood pressure changes or nitric oxide-mediated vascular responsesVictor Dishy, Gbenga G Sofowora, Hitoshi Imamura, et al.
Kidney International|November 25, 2003
The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiographyShai Efrati, Victor Dishy, Michael Averbukh, et al.
Thrombosis and Haemostasis|January 9, 2015
Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysisDolly A Parasrampuria, Thomas Marbury, Nobujo Matsushima, et al.
American Journal of Obstetrics and Gynecology|November 20, 2002
beta2-Adrenergic receptor genotype and preterm deliveryRuth Landau, Hong-Guang Xie, Victor Dishy, et al.
American Journal of Therapeutics|May 17, 2014
Effects of Extended-Release Niacin and Extended-Release Niacin/Laropiprant on the Pharmacokinetics of Simvastatin in Healthy SubjectsBrett Lauring, Victor Dishy, Pieter-Jan De Kam, et al.
Journal of Clinical Pharmacology|June 28, 2019
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of an Oral Formulation of DS-1040, an Inhibitor of the Activated Form of Thrombin-Activatable Fibrinolysis Inhibitor, in Healthy SubjectsJin Zhou, Tharin Limsakun, Ophelia Yin, et al.
Pageof 4